ADP activation induces bFGF binding to platelets in vitro

Upsala Journal of Medical Sciences

Volumn 107, Issue 3, 2002, Pages 165-171

  Akerblom B ^a   Lindahl, T L ^b   Larsson, A ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activation; ADP; bFGF; Blood platelets; Flow cytometry

Indexed keywords

ADENOSINE DIPHOSPHATE; FIBROBLAST GROWTH FACTOR 2; RECOMBINANT PROTEIN;

ARTICLE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; METABOLISM; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; HUMANS; PLATELET ACTIVATION; RECOMBINANT PROTEINS;

EID: 0142228319     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-126     Document Type: Article

References (19)

1. Pincdo, H. M., Verheul, H. M. W., D'Amato, R. J. & Folkman, J. Involvement of platelets in tumour angiogenesis? Lancet, 352: 1775-1777, 1998.
2. Pedersen, L. M. & Milman, N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur. Respir. J., 9: 1826-1830, 1996.
3. Monreal, M., Fernandez-Llamazares, J., Pinol, M., Julian, J. F., Broggi, M., Escola, D. & Abad, A. Platelet count and survival in patients with colorectal cancer-a preliminary study. Thromb. Haemost., 79: 916-918, 1998.
4. Brunner, G., Nguyen, H., Gabrilove, J., Rifkin, D. B. & Wilson, E. L. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood, 81: 631-638, 1993.
5. Mohle, R., Green, D., Moore, M. A., Nachman, R. L. & Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA, 94: 663-668, 1997.
6. Flaumenhaft, R., Moscatelli, D., Saksela, O. & Rifkin, D. B. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J. Cell. Physiol., 140: 75-81, 1989.
7. Lindahl, T. L., Festin, R. & Larsson, A. Studies of fibrinogen binding to platelets by flow cytometry: An improved method for detection of platelet activation. Thromb. Haemost., 68: 221-225, 1992.
8. Lundahl, T. H., Lindahl, T. L., Fagerberg, I. H., Egberg, N., Bunescu, A. & Larsson, A. Activated platelets and impaired platelet function in intensive care patients analyzed by flow cytometry. Blood Coag. Fibrinol., 7: 218-220, 1996.
9. Wilson, E. L., Rifkin, D. B., Kelly, F., Hannocks, M. J. & Gabrilove, J. L. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood, 77: 954-960, 1991.
10. Lazarous, D. F, Shou, M., Scheinowitz, M., Hodge, E., Thirumurti, V., Kitsiou, A. N., Stiber, J. A., Lobo, A. D., Hunsberger, S., Guetta, E., Epstein, S. E. & Unger, E. F. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation, 94: 1074-1082, 1996.
11. Yanagisawa-Miwa, A., Uchida, Y., Nakamura, F., Tomaru, T., Kido, H., Kamijo, T., Sugimoto, T., Kaji, K., Utsuyama, M., Kurashima, C. et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science, 257: 1401-1403, 1992.
12. Miyataka, M., Ishikawa, K. & Katori, R. Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs. Angiology, 49: 381-390, 1998.
13. Watanabe, E., Smith, D. M., Sun, J., Smart, F. W., Delcarpio, J. B., Roberts, T. B., Van Meter, C. H. Jr. & Claycomb, W. C. Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart. Basic. Res. Cardiol., 93: 30-37, 1998.
14. Arras, M., Mollnau, H., Strasser, R., Wenz, R., Ito, W. D, Schaper, J. & Schaper, W. The delivery of angiogenic factors to the heart by microsphere therapy. Nat. Biotechnol., 16: 159-162, 1998.
15. Saksela, O. & Rifkin D. B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell. Biol., 110: 767-775, 1990.
16. Smalling, R. W. A fresh look at the molecular pharmacology of plasminogen activators: from theory to test tube to clinical outcomes. Am. J. Health Syst. Pharm., 54 Suppl 1: S17-22, 1997.
17. Swahn, E. & Wallentin, L. Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). FRISC Study Group. Am. J. Cardiol., 80: 25E-29E, 1997.
18. Larsson, A., Bålöw, R.-M., Lindahl, T. L. & Forsberg, P.-O. Chicken IgG: Utilizing the evolutionary advantage. Poultry Science, 72: 1807-1812, 1993.
19. Vassbotn F. S., Havnen, O. K., Heldin, C. H. & Holmsen, H. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J. Biol. Chem., 269: 13874-13879, 1994.